Related Experiment Video
Updated: May 4, 2026
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Tumor-specific localization of self-assembled nanoparticle PET/MR modalities
István Hajdu1, György Trencsényi, Magdolna Bodnár
1Medical and Health Science Center, University of Debrecen, Egyetem tér 1 H-4032 Debrecen, Hungary. Tel/Fax: +36 52412623 vamosig@med.unideb.hu.
Aim:
The aim of this work was to synthesize and study in vitro and in vivo nanocarriers used as magnetic resonance imaging (MRI) contrast agents that accumulate in tumor cells specifically overexpressing folate receptors.
Materials And Methods:
Nanoparticles were prepared by self-assembly of poly-γ-glutamic acid and chitosan biopolymers and were complexed with gadolinium ions. Folic acid served as a targeting molecule. Rat hepatocellular carcinoma (HeDe) cells overexpressing folate receptors were used as a model system. For in vivo experiments, HeDe cells were transplanted under the renal capsule of F344 rats.
Results:
In vitro results showed the significant internalization of nanoparticles into HeDe cells. MRI measurements revealed that targeting nanocarriers accumulated in tumors. The MRI/PET fusion images resulted in the exact localization of tumors.
Conclusion:
The nanocarrier provides a suitable means for the early diagnosis of tumors based on their overexpression of folate receptors.
More Related Videos
12:24Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013